Clinical Trials Logo

Cancer of Liver clinical trials

View clinical trials related to Cancer of Liver.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06458998 Not yet recruiting - Cirrhosis Clinical Trials

Getting To Implementation: Improving Cancer Screening for Veterans

GTI
Start date: July 15, 2024
Phase: N/A
Study type: Interventional

Gastrointestinal cancers such as colon cancer and liver cancer cause many deaths in the US. Testing could catch these cancers early, helping people live longer. The goal of this study is to compare two different ways of getting more people tested for these cancers: 1) by directly reaching out to the people who need testing or 2) by helping providers fix issues that hold up testing. The main question it aims to answer is: how should healthcare systems go about choosing one or the other? Researchers will look at cancer testing rates over time at sites that are trying these different approaches. They will also survey and interview participants from these sites.

NCT ID: NCT05041335 Not yet recruiting - Cancer Clinical Trials

Wet Heparinized Suction for Abdominal Cancer

EUS Heparin
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or "blood thinner" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptability of the specimens before sending for analysis. You will be randomly assigned (like a flip of a coin) to have either the blood thinner or the salt water solution placed within the needle being used to sample your abdominal tumor and to have either a sieve used or not. You will be one of 42 participants enrolled in this data collection study which includes 1 sites in the United States.

NCT ID: NCT03766776 Not yet recruiting - Cancer of Liver Clinical Trials

Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

ATAHC
Start date: December 31, 2018
Phase: N/A
Study type: Interventional

This is a prospective, one-arm, exploratory clinical study to observe and evaluate the efficacy and safety of Anlotinib hydrochloride capsules in patients with advanced liver cancer.

NCT ID: NCT03607643 Not yet recruiting - Clinical trials for Glioblastoma Multiforme

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Start date: January 15, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

A Randomized, Double-Blind, Placebo-Controlled, Parallel, Multi-Center Study to Assess the Efficacy of BRCX014 Combined with Standard-Of-Care Treatment in Subjects with Glioblastoma Multiforme, Multiple Myeloma, and GI Malignancies